Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
拉替拉韦方案在4周至2岁感染人类免疫缺陷病毒并接受利福平治疗结核病的儿童中的药代动力学和安全性
期刊:Journal of the Pediatric Infectious Diseases Society
影响因子:2.6
doi:10.1093/jpids/piaa039
Krogstad, Paul; Samson, Pearl; Acosta, Edward P; Moye, Jack; Townley, Ellen; Bradford, Sarah; Brown, Emily; Denson, Kayla; Graham, Bobbie; Hovind, Laura; Sise, Thucuma; Teppler, Hedy; Mathiba, Sisinyana Ruth; Fairlie, Lee; Winckler, Jana L; Slade, Gretchen; Meyers, Tammy
